Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Anticancer Res ; 41(4): 2193-2195, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33813433

RESUMEN

BACKGROUND/AIM: Since January 2020, coronavirus disease (COVID-19) cases have been confirmed in Japan, and the number of patients with COVID-19 has been increasing. Two emergency declarations have been made previously and one is currently in effect. Based on our experience of a situation that could affect cancer treatment, this study retrospectively examined the correlation between perioperative anticancer therapy and COVID-19 incidence in patients with breast cancer. PATIENTS AND METHODS: Patients who underwent perioperative anticancer therapy for breast cancer at our hospital from February 2020 to February 2021 were included in this study. The presence or absence of COVID-19, timing of anticancer drug initiation, and clinical data were collected. RESULTS: No cases of COVID-19 were diagnosed in patients receiving perioperative anticancer therapy at our hospital. CONCLUSION: Regimen modification, active use of supportive care, and patient lifestyle were factors reducing the incidence of COVID-19.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Neoplasias de la Mama , COVID-19/epidemiología , Atención Perioperativa/métodos , Anciano , Anciano de 80 o más Años , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/patología , Neoplasias de la Mama/cirugía , Quimioterapia Adyuvante/estadística & datos numéricos , Terapia Combinada , Femenino , Humanos , Huésped Inmunocomprometido , Incidencia , Japón/epidemiología , Persona de Mediana Edad , Terapia Neoadyuvante/estadística & datos numéricos , Atención Perioperativa/efectos adversos , Atención Perioperativa/estadística & datos numéricos , Estudios Retrospectivos , Factores de Riesgo , SARS-CoV-2/fisiología
2.
Asian J Endosc Surg ; 12(2): 222-226, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30549252

RESUMEN

INTRODUCTION: Recently, single-incision laparoscopic cholecystectomy has been accepted as an alternative to conventional laparoscopic cholecystectomy. The aim of this study was to retrospectively evaluate the safety and feasibility of unique gallbladder retraction methods using an ENDOLOOP® (Ethicon, Tokyo, Japan) and Lapaherclosure™ (Hakko Medical, Tokyo, Japan). MATERIALS AND SURGICAL TECHNIQUE: From May 2013 to April 2015, 77 patients underwent single-incision laparoscopic cholecystectomy with this retraction technique. During the same period, conventional laparoscopic cholecystectomy was performed in 85 patients; these patients were the control group. The patients' data, including the operative time, total blood loss, conversion rate to laparotomy, and perioperative complications, were compared. Alexis® Wound Retractor XS (Applied Medical, Tokyo, Japan) was inserted through a 25-30-mm vertical transumbilical incision to prevent bile contamination. Next, a SILS Port (Covidien, Tokyo, Japan) was inserted. A flexible 5-mm laparoscope was inserted through the port with a grasper (SILS Clinch, Covidien) and a normal 5-mm scalpel. The fundus of the gallbladder was tied by the ENDOLOOP. The Lapaherclosure was then directly inserted through a right lower intercostal space to capture and pull the Lapaherclosure out. After the cystic artery and duct were cut, the resected gallbladder was directly extracted from the umbilical incision. DISCUSSION: Several methods and devices have been developed to perform single-incision laparoscopic cholecystectomy, including the suturing method, the Mini Loop Retractor II (Covidien), and the EndoGrab (Virtual Ports, Caesarea, Israel). However, considering medical costs and safety, our retraction method seems to be feasible and comparable to existing methods.


Asunto(s)
Colecistectomía Laparoscópica/métodos , Vesícula Biliar/cirugía , Instrumentos Quirúrgicos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
3.
Surg Case Rep ; 3(1): 128, 2017 Dec 19.
Artículo en Inglés | MEDLINE | ID: mdl-29260424

RESUMEN

BACKGROUND: Subareolar breast abscess (SBA) is a rare infectious disease of the breast in male patients. CASE PRESENTATION: Herein, we report two male patients with SBA. Patient 1 was initially diagnosed with a malignant tumor based on imaging findings; ultrasonography revealed a hypoechoic mass with blood flow. Patient 2 was diagnosed with inflammatory changes to his nipple; ultrasonography findings supported the diagnosis with an irregular hypoechoic mass with blood flow. Both patients received a cytological or histological biopsy preoperatively, which showed an abscess without malignant cells. CONCLUSION: These cases serve as an important reminder to consider complete resection of the tumor including the responsible mammary duct (tumor and duct resection (TDR)) for curative therapy of SBA.

4.
Eur J Dermatol ; 16(4): 420-2, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16935802

RESUMEN

Paraneoplastic pemphigus (PNP) is an autoimmune mucocutaneous disease, associated with neoplasia, which has characteristic clinical, histological and immunological features. While respiratory epithelial involvement has been described in several cases, lesions in the colon epithelium have never been reported. We describe a 57-year-old Japanese woman with PNP who had many aphthae-like erosions on the colon epithelium, in addition to typical mucocutaneous PNP lesions. The intestinal erosions had histological features similar to those of PNP and linear deposition of complement, but not IgG, was observed along the colon epithelial basement membrane.


Asunto(s)
Colon/patología , Mucosa Intestinal/patología , Síndromes Paraneoplásicos/patología , Pénfigo/patología , Femenino , Humanos , Persona de Mediana Edad , Índice de Severidad de la Enfermedad
5.
Arch Dermatol ; 139(8): 1007-11, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12925388

RESUMEN

OBJECTIVE: To develop a practical technique to distinguish autoimmune subepidermal bullous diseases. DESIGN: A prospective study. SETTING: Academic referral center-the Department of Dermatology, Medical University of Warsaw. Patients Forty-two patients fulfilling clinical, immunological, and/or immunoelectron microscopic criteria for bullous pemphigoid (n = 31), mucous membrane pemphigoid (n = 6), or epidermolysis bullosa acquisita (n = 5), diagnosed as having disease and treated from January 1, 1997, to December 31, 2002. MAIN OUTCOME MEASURES: We applied laser scanning confocal microscopy to determine the localization of in vivo-bound IgG at the basement membrane zone in biopsy specimens taken from patients' skin to compare the localization of basement membrane zone markers: antibody against beta4 integrin, antibody against laminin 5, and antibody against type IV collagen. In vivo-bound IgG was visualized by labeling with fluorescein isothiocyanate-conjugated anti-human IgG antibody, whereas basement membrane zone markers were labeled with anti-mouse Cy5-conjugated antibodies. RESULTS: In patients with bullous pemphigoid, in vivo-bound IgG was localized on the epidermal side of laminin 5 and co-localized with beta4 integrin. In patients with mucous membrane pemphigoid, IgG was in vivo bound to the dermal-epidermal junction between localization of laminin 5 and type IV collagen. In patients with epidermolysis bullosa acquisita, in vivo-bound IgG was present on the dermal side of type IV collagen. CONCLUSIONS: Laser scanning confocal microscopy allows precise localization of in vivo-bound IgG in patients' skin and, thus, it is a rapid method for the differentiation of mucous membrane pemphigoid from bullous pemphigoid and epidermolysis bullosa acquisita. This tool is suitable for the routine diagnosis of individual patients and for retrospective studies. This method is of special value in those patients in whom circulating autoantibodies are not detectable.


Asunto(s)
Epidermis/ultraestructura , Epidermólisis Ampollosa Adquirida/patología , Inmunoglobulina G/ultraestructura , Microscopía Confocal , Penfigoide Benigno de la Membrana Mucosa/patología , Penfigoide Ampolloso/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Membrana Basal/ultraestructura , Niño , Preescolar , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Estudios Prospectivos
6.
J Dermatol ; 30(4): 321-5, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12707469

RESUMEN

We describe a 54-year-old man with hepatitis C virus (HCV) infection-associated cryoglobulinemia type III. The patient had suffered from cold-induced urticaria that left purpuric eruptions up to 1 cm in diameter, intermittent migratory joint pain for seven years and mild liver dysfunction for nine years. Hemophilia A was diagnosed when the patient was 26 years old, and he was then given infusions of factor VIII for a short time. In both skin biopsy samples from urticarial and purpuric eruptions, mild inflammatory infiltration by polymorphonuclear leukocytes with nuclear dust, extravasation of erythrocytes and deposition of IgM and C3 in the superficial blood vessels were observed. After antiviral treatment with interferon-beta, the clinical symptoms and the cryoglobulin and HCV-RNA in the serum disappeared. There has been no recurrence in the subsequent nine years.


Asunto(s)
Crioglobulinemia/complicaciones , Crioglobulinemia/tratamiento farmacológico , Hepatitis C Crónica/complicaciones , Interferón beta/uso terapéutico , Púrpura/tratamiento farmacológico , Urticaria/tratamiento farmacológico , Biopsia con Aguja , Crioglobulinemia/diagnóstico , Estudios de Seguimiento , Hepatitis C Crónica/diagnóstico , Humanos , Inmunohistoquímica , Extremidad Inferior , Masculino , Persona de Mediana Edad , Púrpura/complicaciones , Púrpura/patología , Medición de Riesgo , Resultado del Tratamiento , Urticaria/complicaciones , Urticaria/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...